| Compound Information | SONAR Target prediction | | Name: | 3-alpha,21-Dihydroxy-5-alpha-pregnan-20-one | | Unique Identifier: | LOPAC 01126 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | C21H34O3 | | Molecular Weight: | 301.231 g/mol | | X log p: | -0.154 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 17.07 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 3 | | Rotatable Bond Count: | 2 | | Canonical Smiles: | CC12CCC(O)CC1CCC1C3CCC(C(=O)CO)C3(C)CCC12 | | Class: | GABA | | Action: | Modulator | | Selectivity: | GABA-A |
| Species: |
4932 |
| Condition: |
NOP16 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.7533±0.0157685 |
| Normalized OD Score: sc h |
1.0233±0.00464465 |
| Z-Score: |
1.0756±0.0890409 |
| p-Value: |
0.283038 |
| Z-Factor: |
-4.55384 |
| Fitness Defect: |
1.2622 |
| Bioactivity Statement: |
Nonactive |
| Experimental Conditions | | | Library: | Lopac | | Plate Number and Position: | 12|B8 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 0.00 Celcius | | Date: | 2005-04-22 YYYY-MM-DD | | Plate CH Control (+): | 0.04555±0.00080 | | Plate DMSO Control (-): | 0.7341249999999999±0.07272 | | Plate Z-Factor: | 0.8411 |
|  png
ps
pdf |
| 630364 |
5-hydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopent
a[a]phenanthren-4-one |
| 630405 |
17-acetyl-17-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren
-3-one |
| 827465 |
(2S,4S)-2-hydroxy-2-methyl-4-tert-butyl-cyclohexan-1-one |
| 1268070 |
(1R,2S,5R)-2-hydroxy-2,6,6-trimethyl-norpinan-3-one |
| 2729261 |
(5S,8R,9S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclo
penta[a]phenanthren-3-one |
| 2750706 |
1-(1-hydroxy-2-methyl-5-propan-2-yl-cyclohexyl)ethanone |
| internal high similarity DBLink | Rows returned: 1 | |
| active | Cluster 17389 | Additional Members: 4 | Rows returned: 2 | |
|
